Upgrade to SI Premium - Free Trial

Enliven Therapeutics (ELVN) PT Raised to $56 at H.C. Wainwright

March 26, 2026 6:42 AM
(Updated - March 26, 2026 6:43 AM EDT)

H.C. Wainwright analyst Robert Burns raised the price target on Enliven ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change